China Literature Limited (China Lit) disclosed that it repurchased 2.20 million ordinary shares on the Hong Kong Stock Exchange between 2 September and 14 September 2026. The shares, all earmarked for cancellation, were acquired at volume-weighted average prices ranging from HK$19.37 to HK$21.44 per share, for an aggregate consideration of approximately HK$44.82 million.

Key transaction details (shares pending cancellation): • 02 Sep 2026: 0.40 million shares at HK$20.34 • 03 Sep 2026: 0.40 million shares at HK$20.18 • 07 Sep 2026: 0.40 million shares at HK$21.44 • 08 Sep 2026: 0.20 million shares at HK$21.32 • 09 Sep 2026: 0.20 million shares at HK$20.07 • 10 Sep 2026: 0.20 million shares at HK$19.71 • 11 Sep 2026: 0.20 million shares at HK$19.68 • 14 Sep 2026: 0.20 million shares at HK$19.37

The weighted average repurchase price for the eight transactions stands at HK$20.37 per share.

Capital structure impact: • Issued shares (excluding treasury shares) remained at 1.01 billion as of 14 September 2026 because the repurchased shares had not yet been cancelled. • Once cancellation is completed, the share count will decline by roughly 2.17 million shares, equivalent to about 0.21% of the current issued share capital.

Repurchase authority status: • The company’s general mandate approved on 2 June 2026 allows for the buy-back of up to 102.15 million shares. • Cumulative repurchases under this mandate total 15.85 million shares, utilising approximately 1.55% of the issued shares outstanding at the mandate date. • In line with Hong Kong Listing Rules, China Lit is restricted from issuing new shares for 30 days following the 14 September transaction, implying a moratorium until 14 October 2026.

The company confirmed all repurchases were executed on the Hong Kong Stock Exchange in compliance with Main Board Rule 10.06 and that no material changes have occurred to the repurchase explanatory statement dated 30 April 2026.